drugset / Trial / NCT03140358
The Use of Atropine 0.01% in the Prevention and Control of Myopia (ATOM3)
Phase 3
Active not recruiting
300 enrolled
Singapore National Eye Centre
National Medical Research Council (NMRC), Singapore · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Study of low dose atropine in preventing the onset and progression of myopia in high risk children with pre-myopia or low-myopia.
Timeline
- Start
- 2017-04-21
- Primary completion
- 2024-12-31
- Completion
- 2025-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Atropine | Other / unclassified | 0.01 % | — |